UPXI (NASDAQ) is a cross-listing of GRVI (NASDAQ). Showing primary listing data.
GRVI
Upexi, Inc.
1W: -9.0%
1M: +2.1%
3M: -10.2%
1Y: -27.2%
$4.95
Last traded 2022-08-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$88.9M
52W Range—
Volume30,412
Avg Volume50,443
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAllan J. Marshall
Employees122
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-06-24
Websitegroveinc.io
1710 Whitney Mesa Drive
Henderson, NV 89014
US
Henderson, NV 89014
US
701-353-5425
About Upexi, Inc.
Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada.
Latest News
Investors Buy Large Volume of Call Options on Upexi (NASDAQ:UPXI)
Upexi, Inc. (UPXI) Q2 2026 Earnings Call Transcript
Upexi Reports Fiscal Second Quarter 2026 Financial Results
Upexi to Participate in A.G.P.'s Digital Asset Innovation Summit on February 22-25
Upexi Announces Pricing of $7.4 Million Registered Direct Offering With a Single Institutional Investor
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BAZAN ANTHONY P. | 275,000 | $4.60 | 2023-08-17 | |
| Salkind Gene | P-Purchase | 125,000 | $4.00 | 2022-03-30 |
| MARSHALL ALLAN | 0 | — | 2021-08-30 | |
| MARSHALL ALLAN | 277,778 | — | 2021-08-30 | |
| MARSHALL ALLAN | 833,333 | — | 2021-08-30 |